Tokyo

London

New York

Register

Sign In

EUR/USD

1.1193

0.0043

0.39%

GBP/USD

1.2720

0.0040

0.32%

USD/JPY

111.30

0.0070

0.01%

USD/CHF

0.9694

-0.0026

-0.26%

EUR/GBP

0.8800

0.0006

0.07%

USD/CAD

1.3269

0.0034

0.26%

NZD/USD

0.7281

0.0015

0.20%

EUR/JPY

124.58

0.4895

0.39%

EUR/CHF

1.0850

0.0014

0.13%

Aclaris Therapts Cmn

NASDAQ: ACRSHealthcare / Biotechnology / USA
27.18+1.16+4.46%Vol 966 9191Y Perf 49.26%
Jun 23rd, 2017 16:00
BID26.89 ASK29.50
Open25.97 Previous Close26.02
Pre-Market- After-Trading27.18
 - -%  - -%
Target Price
42.80 
Analyst Rating
Strong Buy 1.00
Potencial %
57.47 
Finscreener Ranking
—    -
Insiders Trans % 3/6/12M
-/-100/-100 
Value Ranking
—    -
Insiders Value % 3/6/12M
-/-100/-100 
Growth Ranking
—    -
Insiders Shares Cnt. % 3/6/12M
-/-100/-100 
Income Ranking
—    -
Market Cap (mil)696 
Earnings Rating
Buy
Price Range Ratio 52wk %
62.41 
Earnings Date
10th Aug 2017

Today's Price Range

25.8227.19

 

52wk Range

17.1033.25

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
4.88%
3 Months
-12.12%
6 Months
-7.34%
1 Year
49.26%
3 Years
-
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
ACRS27.181.16004.46
AAPL146.350.72000.49
GOOG965.598.50000.89
MSFT71.210.95001.35
XOM81.610.53000.65
WFC52.45-0.0400-0.08
JNJ136.430.38000.28
FB155.071.67001.09
GE27.570.02000.07
JPM86.86-0.1600-0.18
...

TickerPriceChg.%52 Week High
EQT56.198.0080.61
AA31.094.3339.78
SWN5.794.3215.59
RRC22.263.8745.76
COG23.743.8526.74
WDC93.343.4295.00
TRIP36.963.4171.69
OKE49.192.9359.47
MOS22.972.9134.36
RIG8.092.8016.66
FCX11.762.7117.06
AKAM51.302.5671.64
ALGN153.502.55154.85
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 27.20
Current Ratio 27.90
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -
Leverage Ratio 1.00
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 4.25
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -16.70
Cash Flow Per Share -1.76
Price to Tangible Book4.25
Book Value per Share6.00
Enterprise Value (in ths.)528 019
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-
ROE last 12 Months -39.97
Return on Assets (5Y Avg) -
ROA last 12 Months -38.40
Return on Capital (5Y Avg) -
ROC last 12 Months -39.10
Return on invested Capital Q -7.62
Return on invested Capital Y-36.70
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2017-0.54-0.4811.11
Q04 2016-0.59-0.4916.95
Q03 2016-0.68-0.5026.47
Q02 2016-0.61-0.62-1.64
Q01 2016-0.50-0.65-30.00
Q04 2015-0.40-0.2830.00
Q03 2015-1.46-5.11-250.00
----
Earnings Per EndEstimateRevision %Trend
6/2017 QR-0.680.00-
9/2017 QR-0.91-1.11Negative
12/2017 FY-3.202.44Positive
12/2018 FY-3.406.34Positive
Next Report Date10th Aug 2017
Estimated EPS Next Report-0.68
Estimates Count3
EPS Growth Next 5 Years %0.00
Volume Overview
Volume966 919
Shares Outstanding (in ths.)26 730
Trades Count1 532
Dollar Volume21 610 502
Avg. Volume275 611
Avg. Weekly Volume408 493
Avg. Monthly Volume395 688
Avg. Quarterly Volume306 317

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

67%33%

Bearish Bullish

74%26%

Bearish Bullish

75%25%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (100.00 %)
5 (100.00 %)
5 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

Plus500
x